HomeAPRE • NASDAQ
add
Aprea Therapeutics Inc
Previous close
$5.37
Day range
$5.06 - $5.37
Year range
$2.78 - $8.85
Market cap
28.07M USD
Avg Volume
14.59K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 14.08K | — |
Operating expense | 1.64M | -22.49% |
Net income | -3.44M | -40.99% |
Net profit margin | -24.46K | — |
Earnings per share | -0.92 | 0.00% |
EBITDA | -3.67M | -38.46% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 21.61M | -24.94% |
Total assets | 22.65M | -24.89% |
Total liabilities | 4.39M | 37.00% |
Total equity | 18.26M | — |
Shares outstanding | 5.43M | — |
Price to book | 1.18 | — |
Return on assets | -37.95% | — |
Return on capital | -46.09% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -3.44M | -40.99% |
Cash from operations | -3.74M | 6.99% |
Cash from investing | -7.15K | — |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -3.75M | 13.40% |
Free cash flow | -2.62M | 20.33% |
About
Website
Employees
7